Urothelial cancer
Showing 9976 - 10000 of >10,000
Gastric Cancer, Cancer of Stomach, Gastric Adenocarcinoma Trial in Woodville South (IMU-131, Irinotecan or Paclitaxel,
Not yet recruiting
- Gastric Cancer
- +5 more
- IMU-131
- +2 more
-
Woodville South, South Australia, AustraliaThe Queen Elizabeth Hospital
Apr 12, 2022
Neuroendocrine Neoplasms Including Adrenocortical Carcinoma
Recruiting
- Neuroendocrine Tumors
- Carcinoma, Neuroendocrine
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Chemo Induced Peripheral Neuropathy Trial (Omeprazole)
Not yet recruiting
- Chemotherapy Induced Peripheral Neuropathy
- (no location specified)
Jan 10, 2023
Classical Hodgkin Lymphoma, Relapsed Cancer, Refractory Cancer Trial in Toronto (Pembrolizumab, Bendamustine Hydrochloride)
Recruiting
- Classical Hodgkin Lymphoma
- +2 more
- Pembrolizumab
- Bendamustine Hydrochloride
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Dec 31, 2021
Bone and Joints, Brain and Nervous System, Leukemia, NOS Trial in San Francisco (GOLD Program, Treatment as usual (TAU))
Recruiting
- Bone and Joints
- +4 more
- GOLD Program
- Treatment as usual (TAU)
-
San Francisco, CaliforniaStanford Cancer Institute
Jun 8, 2022
ER+ Breast Cancer, Breast Cancer, Aromatase Inhibitors Trial in Boston (White Wine, Grape Juice)
Not yet recruiting
- ER+ Breast Cancer
- +2 more
- White Wine
- Grape Juice
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Aug 1, 2022
Lymph Node Cancer Metastatic Trial in Hospitalet de Llobregat (Axillary mapping reverse)
Recruiting
- Lymph Node Cancer Metastatic
- Axillary mapping reverse
-
Hospitalet de Llobregat, Barcelona, SpainHospital de Bellvitge
Aug 2, 2022
Advanced Colorectal Cancer Trial (Bevacizumab combined with Oxaliplatin and TAS-102)
Not yet recruiting
- Advanced Colorectal Cancer
- Bevacizumab combined with Oxaliplatin and TAS-102
- (no location specified)
May 16, 2022
Lung Cancer, Nonsmall Cell Trial (Immunonutrition, Control dietary intervention)
Not yet recruiting
- Lung Cancer, Nonsmall Cell
- Immunonutrition
- Control dietary intervention
- (no location specified)
May 18, 2022
Esophageal Cancer, Indocyanine Green Trial in Fuzhou (Indocyanine green solution)
Recruiting
- Esophageal Cancer
- Indocyanine Green
- Indocyanine green solution
-
Fuzhou, Fujian, ChinaFujian Medical University Union Hospital
Jan 23, 2022
ctDNA During Neoadjuvant Chemotherapy for Breast Cancer.
Recruiting
- Breast Cancer Female
- +4 more
-
Ho Chi Minh City, Vietnam
- +1 more
Oct 16, 2023
Locally Advanced, High-Risk, Rectal Cancer Trial in Guangzhou (Toripalimab, short-term radiotherapy, Oxaliplatin)
Not yet recruiting
- Locally Advanced
- +3 more
- Toripalimab
- +3 more
-
Guangzhou, Guangdong, ChinaNanfang Hospital Southern Medical University
May 17, 2023
Quality of Life, Cognitive Decline, Fatigue Trial in Kennesaw (Physical activity experiment, Balance and flexibility control)
Recruiting
- Quality of Life
- +5 more
- Physical activity experiment
- Balance and flexibility control
-
Kennesaw, GeorgiaAmerican Cancer Society (virtual recruitment and study)
Jun 15, 2022
NSCLC Trial in Guangzhou (TGRX-326)
Recruiting
- Non-small Cell Lung Cancer
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jul 18, 2023
Adolescent Cancer Trial (lifestyle and physical exercise)
Not yet recruiting
- Adolescent Cancer
- lifestyle and physical exercise
- (no location specified)
Sep 12, 2022
Advanced Breast Cancer Trial in Changsha (TQB3909 tablets)
Recruiting
- Advanced Breast Cancer
- TQB3909 tablets
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Mar 16, 2023
Childhood Cancer, Late Effects Trial in Aarau (Physical examination, diagnostic tests, laboratory tests, Personal history)
Recruiting
- Childhood Cancer
- Late Effects
- Physical examination, diagnostic tests, laboratory tests
- Personal history
-
Aarau, SwitzerlandDivision of Oncology - Hematology, Department of Pediatrics, Kan
Aug 16, 2022
Esophageal Cancer, Squamous Cell Esophagus Cancer, Adenocarcinoma Esophagus Trial in Boston (Pembrolizumab)
Active, not recruiting
- Esophageal Cancer
- +2 more
-
Boston, Massachusetts
- +2 more
Apr 7, 2022
Cervical Carcinoma, Chemoradiotherapy, Anti-programmed Cell Death Receptor 1 Trial in Beijing (Camrelizumab plus Concurrent
Recruiting
- Cervical Carcinoma
- +8 more
- Camrelizumab plus Concurrent chemoradiotherapy
-
Beijing, Beijing, ChinaLei Li
Apr 5, 2022
Chronicization of Radiation-induced Acute Intestinal Injury
Not yet recruiting
- Radiation-induced Intestinal Injury
- NCRT+TME
- (no location specified)
Feb 19, 2023
Chronicization of Radiation-induced Acute Intestinal Injury
Not yet recruiting
- Radiation-induced Intestinal Injury
- NCRT+TME
- (no location specified)
Feb 19, 2023
Nomogram Predicting Survival in Chinese SCLC Patients
Completed
- Small Cell Lung Cancer
- initial chemotherapy response
- (no location specified)
Jan 8, 2023
Bladder Cancer, Radical Cystectomy Trial in Ann Arbor (CLEAR Care Companion (CC) application)
Recruiting
- Bladder Cancer
- Radical Cystectomy
- CLEAR Care Companion (CC) application
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Jan 9, 2023
Alzheimer, Late Onset, Stroke, Heart Failure Trial in Yilan (Health Education Manual, manual)
Completed
- Alzheimer Disease, Late Onset
- +7 more
- Health Education Manual
- manual
-
Yilan, TaiwanWen-Shiou Pan
Jun 6, 2022